Aquestive Therapeutics (NASDAQ:AQST) announced Tuesday the completion of its New Drug Application in the U.S. for Anaphylm, a ...
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has introduced the ADRENALIN® ready-to-use premixed intravenous (IV) bag, the first FDA-approved epinephrine premixed bag prepared directly by the manufacturer.
Bupivacaine HCl 2.5mg/mL, 5mg/mL; epinephrine 1:200000; soln for inj. Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical ...